BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29322789)

  • 1. RNA interference-mediated silencing of aquaporin (AQP)-5 hinders angiogenesis of colorectal tumor by suppressing the production of vascular endothelial growth factor.
    Wang W; Li Q; Yang T; Li D; Ding F; Sun H; Bai G
    Neoplasma; 2018; 65(1):55-65. PubMed ID: 29322789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Liang H; Zhong Y; Zhou S; Peng L
    Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer.
    Yorozu A; Yamamoto E; Niinuma T; Tsuyada A; Maruyama R; Kitajima H; Numata Y; Kai M; Sudo G; Kubo T; Nishidate T; Okita K; Takemasa I; Nakase H; Sugai T; Takano K; Suzuki H
    Cancer Sci; 2020 May; 111(5):1631-1644. PubMed ID: 32086986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
    Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
    Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
    Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
    Yang L; Xiao M; Li X; Tang Y; Wang YL
    Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
    Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
    Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer.
    Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G
    Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755
    [No Abstract]   [Full Text] [Related]  

  • 11. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer.
    Kim SL; Lee ST; Trang KT; Kim SH; Kim IH; Lee SO; Kim DG; Kim SW
    Int J Mol Med; 2014 May; 33(5):1261-7. PubMed ID: 24573421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
    Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
    Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Stemness-High Human Colorectal Cancer Cells Promote Angiogenesis by Producing Higher Amounts of Angiogenic Cytokines via Activation of the Egfr/Akt/Nf-κB Pathway.
    Chung SY; Chao TC; Su Y
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progastrin a new pro-angiogenic factor in colorectal cancer.
    Najib S; Kowalski-Chauvel A; Do C; Roche S; Cohen-Jonathan-Moyal E; Seva C
    Oncogene; 2015 Jun; 34(24):3120-30. PubMed ID: 25109333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.